Personalis (NASDAQ:PSNL) Trading 7.5% Higher - Here's Why

Key Points

• Shares of Personalis, Inc. (NASDAQ: PSNL) increased by 7.5%, trading at $6.26, despite a 60% drop in average trading volume.
• Analysts have mixed opinions on the stock, with Wall Street Zen downgrading it to "sell," while HC Wainwright maintains a "buy" rating with an $8.50 price target.
• Personalis reported a $0.23 EPS for the last quarter, surpassing estimates, but had negative margins and revenues below expectations at $17.20 million.

Personalis, Inc. (NASDAQ:PSNL - Get Free Report)'s stock price rose 7.5% on Friday . The company traded as high as $6.21 and last traded at $6.26. Approximately 413,958 shares were traded during trading, a decline of 60% from the average daily volume of 1,040,232 shares. The stock had previously closed at $5.82.

Analysts Set New Price Targets

PSNL has been the subject of a number of recent research reports. BTIG Research set a $6.00 price target on shares of Personalis in a research note on Wednesday, August 6th. Wall Street Zen upgraded shares of Personalis from a "sell" rating to a "hold" rating in a research note on Saturday. Finally, HC Wainwright reiterated a "buy" rating and set a $8.50 price target on shares of Personalis in a research note on Monday, September 8th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Personalis presently has a consensus rating of "Buy" and a consensus target price of $7.42.

Personalis Stock Up 1.0%

The stock's fifty day moving average price is $5.41 and its 200-day moving average price is $4.93.

Personalis (NASDAQ:PSNL - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.25) by $0.02. The business had revenue of $17.20 million during the quarter, compared to the consensus estimate of $20.12 million. Personalis had a negative net margin of 113.70% and a negative return on equity of 47.57%. Personalis has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts forecast that Personalis, Inc. will post -1.4 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Howland Capital Management LLC raised its position in shares of Personalis by 0.9% in the second quarter. Howland Capital Management LLC now owns 285,308 shares of the company's stock valued at $1,872,000 after buying an additional 2,500 shares during the last quarter. Man Group plc acquired a new stake in Personalis during the second quarter worth approximately $324,000. BNP Paribas Financial Markets grew its stake in Personalis by 406.4% in the 2nd quarter. BNP Paribas Financial Markets now owns 6,451 shares of the company's stock worth $42,000 after acquiring an additional 5,177 shares during the period. Bank of America Corp DE raised its holdings in Personalis by 10.5% in the 2nd quarter. Bank of America Corp DE now owns 222,011 shares of the company's stock valued at $1,456,000 after acquiring an additional 21,009 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in Personalis by 1,172.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 329,865 shares of the company's stock valued at $2,164,000 after acquiring an additional 303,933 shares during the last quarter. 61.91% of the stock is currently owned by hedge funds and other institutional investors.

Personalis Company Profile

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.